SARS-CoV-2 Antibody Response to Symptoms Indicative of COVID-19 in a Non-Infected Population in Japan: a Cross-Sectional Study-Reference-Cited by-同舟云学术

SARS-CoV-2 Antibody Response to Symptoms Indicative of COVID-19 in a Non-Infected Population in Japan: a Cross-Sectional Study

Published:2023-01-31 Issue:1 Volume:76 Page:46-54
ISSN:1344-6304
Container-title:Japanese Journal of Infectious Diseases
language:en
Short-container-title:Jpn J Infect Dis

Author:

Tanaka Shiori¹,Umezawa Jun²,Yamaji Taiki³,Abe Sarah K.¹,Hamada Akinobu⁴,Kobayashi Osamu⁵,Ushijima Toshikazu⁶,Inoue Manami¹

Affiliation:

1. Division of Prevention, National Cancer Center, Japan

2. Division of Cohort Research, National Cancer Center, Japan

3. Division of Epidemiology, Institute for Cancer Control, National Cancer Center, Japan

4. Division of Molecular Pharmacology, National Cancer Center, Japan

5. Department of Infectious Diseases, National Cancer Center, Japan

6. Division of Epigenomics, National Cancer Center, Japan

Publisher

Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Link

https://www.jstage.jst.go.jp/article/yoken/76/1/76_JJID.2022.093/_pdf

Reference30 articles.

1. 1. Ministry of Health, Labour and Welfare. Situation report: current situation in Japan. Available at <https://www.mhlw.go.jp/stf/covid-19/kokunainohasseijoukyou_00006.html>. Accessed October 10, 2021.

2. 2. Mohammad MHS. Immune response scenario and vaccine development for SARS-CoV-2 infection. Int Immunopharmacol. 2021;94:107439.

3. 3. Moradi G, Mohamadi Bolbanabad A, Ahmadi S, et al. Persistence assessment of SARS-CoV-2-specific IgG antibody in recovered COVID-19 individuals and its association with clinical symptoms and disease severity: a prospective longitudinal cohort study. Int immunopharmacol. 2021;98:107893.

4. 4. Bryant JE, Azman AS, Ferrari MJ, et al. Serology for SARS-CoV-2: apprehensions, opportunities, and the path forward. Sci Immunol. 2020;5:eabc6347.

5. 5. Schrock JM, Ryan DT, Saber R, et al. Exposure to SARS-CoV-2 within the household is associated with greater symptom severity and stronger antibody responses in a community-based sample of seropositive adults. medRxiv. 2021; doi: 10.1101/2021.03.11.21253421. Preprint.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunogenicity after vaccination of COVID-19 vaccines in patients with cancer: a prospective, single center, observational study;International Journal of Clinical Oncology;2024-02-21

2. Immunogenicity after vaccination of COVID-19 vaccines in patients with cancer: a prospective, single center, observational study;2023-11-29